Screening of potential prodrugs on cells derived from Dupuytren's disease patients

Kraljevic Pavelic, Sandra, Bratulic, Sinisa, Hock, Karlo, Jurisic, Davor, Hranjec, Marijana, Karminski-Zamola, Grace, Zinic, Biserka, Bujak, Maro and Pavelic, Kresimir (2009) Screening of potential prodrugs on cells derived from Dupuytren's disease patients. Biomedicine and Pharmacotherapy, 63 8: 577-585. doi:10.1016/j.biopha.2008.10.005

Author Kraljevic Pavelic, Sandra
Bratulic, Sinisa
Hock, Karlo
Jurisic, Davor
Hranjec, Marijana
Karminski-Zamola, Grace
Zinic, Biserka
Bujak, Maro
Pavelic, Kresimir
Title Screening of potential prodrugs on cells derived from Dupuytren's disease patients
Journal name Biomedicine and Pharmacotherapy   Check publisher's open access policy
ISSN 0753-3322
Publication date 2009
Sub-type Article (original research)
DOI 10.1016/j.biopha.2008.10.005
Open Access Status
Volume 63
Issue 8
Start page 577
End page 585
Total pages 9
Place of publication Issy les Moulineaux, Cedex, France
Publisher Elsevier Masson
Language eng
Abstract Dupuytren's disease (DD) is a fibroproliferative disorder, the cure for which is still limited to surgical excision of the affected fascia, often leading to high recurrence rates. Due to this fact, non-surgical treatments are being investigated, among them those targeting molecular processes of proliferation and differentiation in Dupuytren's cell cultures. Drugs with antiproliferative action may be valuable in DD treatment. Through characterization of changes on DD-specific cells, we, therefore, decided to test the therapeutic potential of new cytostatic drugs for DD treatment and/or for reduction of post-operative recurrence rates. The N-sulfonylpyrimidine derivative, amidino-substituted benzimidazo[1,2-a]quinoline, and amidino dihydrothienothienyl[2,3-c]quinolone hydrochloride, known to affect proliferation processes, were tested for their antiproliferative activity on primary fibroblasts/myofibroblasts cell cultures derived from the palmar fascia of patients with DD. Only amidino dihydrothienothienyl[2,3-c]quinolone hydrochloride acted in a highly specific manner on cells derived from diseased fascia of DD patients and exhibited a low cytotoxic effect. This result might be a consequence of its specific activity on cytoskeleton changes occurring in differentiating cells. A similar short-term differential antiproliferative effect was observed by the N-sulfonylpyrimidine derivative that was, however, completely lost after 6- and 14-day treatments. The amidino-substituted benzimidazo[1,2-a]quinoline exerted a strong non-specific, dose-related antiproliferative activity on cell types.
Keyword Dupuytren's contracture
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Biological Sciences Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 27 Aug 2014, 14:20:22 EST by Gail Walter on behalf of School of Biological Sciences